StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 11/22/2014, (NASDAQ:CBST), $73.6 +0.23, +0.31%, "HOLD" Cubist Pharmaceut Stock
 




  
  

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   11/22/2014   StockRing.com recommends to   "HOLD"   CBST   stock at current price of   $73.6.
Today CBST stock opened at $74.18 and was trading in the daily range of $ 73.072 - 74.18 per share.
Cubist Pharmaceut (NASDAQ:CBST) Market capitalization is $5.615B. CBST average daily volume is 642,529.
On last trading session CBST stock traded 526,348 shares. Also the Short Ratio for (NASDAQ:CBST) stock is 5.70.
Last year Cubist Pharmaceut(NASDAQ:CBST) before taxes (EBITDA) (ttm) earned $203.5M on revenue of $1.165B.
CBST 50-Day Moving Average is $69.22 vs. $73.6 now and 200-Day Moving Average is $67.32 vs. $73.6.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
CBST Earnings Per Share - EPS (ttm) is 0.86. CBST Stock Price Per Earnings ratio - P/E is 85.51.
Cubist Pharmaceut(NASDAQ:CBST) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for CBST stock is $81.27.
In the last 52 weeks CBST stock was trading in the range of $58.50 - 82.12.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+: FF  FTK  PTEN  NR  EXH     ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: PVA  PWE  FOE  GNE  EOX     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



11/22/2014  Saturday, November 22, 2014 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Cubist Pharmaceut (NASDAQ:CBST) Stock. CBST stock opening price was $74.18 per share. Current price of NASDAQ:CBST Stock is $73.6 per share and it is $+0.23, (+0.31%) today and it was trading in the daily range of $73.072 - 74.18 per share. Current Bid Price for (NASDAQ:CBST) stock is $70.37 and the Ask Price is $0.00. In the last 52 weeks CBST stock was trading in the range of $58.50 - 82.12. 50-Day Moving Average for (NASDAQ:CBST) stock is $69.22 and 200-Day Moving Average is $67.32. On average analysts predict that One Year Target Estimated price for (NASDAQ:CBST) stock is $81.27.

Cubist Pharmaceut (NASDAQ:CBST) is rated as a wait on 9/10/2014 1:20:56 AM.

Cubist Pharmaceut (NASDAQ:CBST) Market capitalization is $5.615B. (NASDAQ:CBST) stock average daily volume is 642,529 shares per day. However, on last trading session of Nov 21, 2012 CBST stock traded 526,348 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:CBST) stock is 5.70. On previous trading session CBST Stock closed at $73.37 per share.

Last year Cubist Pharmaceut (NASDAQ:CBST) before taxes (EBITDA) (ttm) earned $203.5M on total revenue of $1.165B. Earnings Per Share - EPS (ttm) for CBST stock is 0.86. Also, (NASDAQ:CBST) Stock Price Per Earnings ratio - P/E is 85.51. Thus, (NASDAQ:CBST) Stock Price/Sales (ttm) ratio is 4.81 and Price/Book (mrq) ratio is 3.62.

(NASDAQ:CBST) Stock does NOT PAY any dividend. So at this time (NASDAQ:CBST) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Cubist Pharmaceut (NASDAQ:CBST) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=CBST

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

11/22/2014 1 Year Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Saturday, November 22, 2014
  
1 Year CBST 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
11/22/2014 5 days Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Saturday, November 22, 2014
  
5 Days CBST 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

11/22/2014 Stock market price quote data for Cubist Pharmaceut (NASDAQ:CBST) Stock on Saturday, November 22, 2014

Last Trade: 73.6
Trade Time: Nov 21
Change: +0.23, (+0.31%)
Prev Close: 73.37
Open: 74.18
Bid: 70.37
Ask: 0.00
1y Target Est: $81.27
50-Day Moving Average: 69.22
200-Day Moving Average:
67.32
Short Ratio: 5.70
Trailing Annual Dividend Rate: 0.00
Day's Range: 73.072 - 74.18
52wk Range: 58.50 - 82.12
Volume: 526,348
Avg Vol: 642,529
Market Cap: 5.615B
P/E (ttm): 85.51
EPS (ttm): 0.86
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 1.165B
Earnings before Tax (EBITDA) (ttm): 203.5M
Price/Sales (ttm): 4.81
Price/Book (mrq): 3.62
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



11/22/2014 Latest stock market news data for Cubist Pharmaceut (NASDAQ:CBST) Stock on Saturday, November 22, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

New Cubist Pharmaceuticals chief executive will be Robert J. Perez
Boston Globe - Oct 20, 2014
Cubist Pharmaceuticals Inc. said Monday it plans to install a new chief executive, a surprise move that raised questions about whether the Lexington company will keep expanding as the leading US maker of antibiotics or become a takeover target.
Cubist To Report 2014 Fiscal Third Quarter Results Today - Bidness ETC
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer - MarketWatch
What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.?
Motley Fool - Apr 4, 2014
Cubist Pharmaceuticals (NASDAQ: CBST ) and Durata Therapeutics (NASDAQ: DRTX ) both won this week with nods by the FDA's advisory panels on each company's antibacterial agents. In two unanimous votes, the FDA panels agreed on the safety and ...
Better Buy: Cubist Pharmaceuticals, Inc. vs. Durata Therapeutics, Inc.
Motley Fool - Mar 20, 2014
Given the bipolar nature of regulatory decisions for biotechs, it's key to understand the risks relative to rewards associated with a company ahead of the event. With that in mind, here is a Foolish comparison of two biotechs, Cubist Pharmaceuticals ...
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy
TheStreet.com - Nov 5, 2014
CUBIST PHARMACEUTICALS INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago.
Wedbush Begins Coverage on Cubist Pharmaceuticals (CBST) - Ticker Report
Cubist Pharmaceuticals Raised to Buy at TheStreet (CBST) - WKRB News
Cubist Pharmaceuticals: Ripe For Acquisition?
Bidness Etc - Aug 18, 2014
Threats from the increase in drug-resistant germs, and the subsequent rise in demand for more effective and high-impact antibiotics has spurred interest in companies such as Cubist Pharmaceuticals Inc (CBST). The Massachusetts-based drug developer has ...
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A - Businessweek
Lilly among those eyeing antibiotic maker Cubist, analyst says - Indianapolis Business Journal
Cubist Pharmaceuticals Rating Lowered to Neutral at Credit Suisse (CBST)
Intercooler - 23 hours ago
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST) was downgraded by equities researchers at Credit Suisse from an “outperform” rating to a “neutral” rating in a research report issued on Thursday, TheFlyOnTheWall.
Wedbush Initiates Coverage On Cubist Pharmaceuticals
Benzinga - Nov 4, 2014
Wedbush initiated coverage on Cubist Pharmaceuticals Inc (NASDAQ: CBST) with a Neutral rating and $70 price target. Analysts led by Heather Behanna commented that "Cubist is in transition from a one-product company to a leader in the antibiotic arena.
Cubist Pharmaceuticals Given "BBB-" Credit Rating (CBST) - WKRB News
Cubist Pharmaceuticals Receives New Coverage from Analysts at SunTrust ... - Ticker Report
Cubist Pharmaceuticals Larger Than S&P 500 Component PerkinElmer
NASDAQ - Sep 4, 2014
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Cubist Pharmaceuticals Inc. (Symbol: CBST) was identified as having a larger market cap than the smaller end of the S&P 500, for example PerkinElmer, Inc.
Cubist Pharmaceuticals Upgraded to Neutral by Zacks (CBST)
WKRB News - Nov 18, 2014
Cubist Pharmaceuticals Inc logo Zacks upgraded shares of Cubist Pharmaceuticals (NASDAQ:CBST) from an underperform rating to a neutral rating in a research report released on Friday morning.
Investor Watch List: Cubist Pharmaceuticals Inc. (CBST), Baker Hughes ... - WallStreet Scope
Cubist Pharmaceuticals Q3 Earnings Beat Expectations
Zacks.com - Oct 23, 2014
Cubist Pharmaceuticals' (CBST - Analyst Report) third-quarter 2014 earnings (excluding special items) of 58 cents per share were well ahead of the Zacks Consensus Estimate of 36 cents due to higher-than-expected revenues.
Stock Traders Purchase High Volume of Cubist Pharmaceuticals Put Options ... - WKRB News
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line ... - Motley Fool

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   


Cubist Pharmaceuticals (CBST) Marked As A Barbarian At The Gate
TheStreet.com
Trade-Ideas LLC identified Cubist Pharmaceuticals ( CBST) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cubist ...

and more »

Stocks.org

Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock
TheStreet.com
Trade-Ideas LLC identified Cubist Pharmaceuticals ( CBST) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate. In addition to specific proprietary factors, Trade-Ideas identified ...
Stock Traders Purchase High Volume of Cubist Pharmaceuticals Put Options ...WKRB News
More Desired Stocks: Nanosphere, Inc. (NASDAQ:NSPH), Cubist ...Street Newswire (registration)
Cubist Pharmaceuticals (CBST) Announces Quarterly Earnings, Beats Estimates ...Ticker Report
sleekmoney -Intercooler
all 28 news articles »

Hottest Healthcare Stocks Now - ACHC BSX CBST GSK
Investorplace.com
Healthcare stocks fell broadly on Wall Street so far on Wednesday, with the sector seeing an overall decline of 0.4%. More broadly, the Dow Jones Industrial Average was up 0.1%, the Nasdaq climbed 0.1% and the S&P 500 increased 0.1%. Some of the ...


Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS
Investorplace.com
More broadly, the Dow Jones Industrial Average rose 1.2%, the Nasdaq climbed 1.5% and the S&P 500 pushed 1.2% higher. Some of the biggest gainers among healthcare stocks include: Mannkind Corp (MNKD): MNKD stock is up 4.8% today.


Biggest Movers in Healthcare Stocks Now - ACHN IRWD PCRX CBST
Investorplace.com
More broadly, the Dow Jones Industrial Average climbed 0.5%, the Nasdaq pushed 0.4% higher and the S&P 500 climbed 0.5%. Some of the biggest gainers among healthcare stocks include: Achillion Pharmaceuticals (ACHN): ACHN stock is up 10.5% ...


Biggest Movers in Healthcare Stocks Now – HMSY AZN CBPO CBST
Investorplace.com
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%. More broadly, the Dow Jones Industrial Average pushed 0.2% higher, the Nasdaq rose 0.1% and the S&P 500 increased 0.2%. Some of ...


iStockAnalyst (press release)

Cubist Pharmaceuticals Inc. (CBST): Poised To Pop on FDA OK
iStockAnalyst (press release)
An approval from the Food and Drug Administration (FDA) usually puts a charge into the stock price of the beneficiary(s) of the thumbs up. On the other hand, the plug can be pulled and the stock price drained on a "No" from the FDA. Any investors that ...
Cubist Pharmaceuticals (CBST) Gets FDA Approval For New AntibioticCorvus Business Newswire
Cubist and Durata Heat Up Antibiotic MarketMotley Fool
Cubist Readies For Takeoff With New Antibiotic LaunchInvestor's Business Daily
Yahoo News
all 123 news articles »

Cubist Pharmaceuticals EVP Unloads $3146894 in Stock (CBST)
Ticker Report
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) EVP Steven C. Gilman sold 48,125 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $65.39, for a total ...

and more »

Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's Post-Market Leader Stock
TheStreet.com
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products for various medical needs in the acute care environment in the United States. CBST has a PE ratio of 234.3 ...

and more »

Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy
TheStreet.com
"We rate CUBIST PHARMACEUTICALS INC (CBST) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover ...
Wedbush Begins Coverage on Cubist Pharmaceuticals (CBST)Ticker Report
Cubist Pharmaceuticals Raised to Buy at TheStreet (CBST)WKRB News
Cubist Pharmaceuticals Raised to "Buy" at TheStreet (CBST)sleekmoney
Watch List News (press release) -Intercooler
all 8 news articles »

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


11/22/2014 News from StockRing Blog about Cubist Pharmaceut (NASDAQ:CBST) Stock on Saturday, November 22, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.